Access cutting-edge light chain amyloidosis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access light chain amyloidosis specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related light chain amyloidosis treatment provided free
The purpose of this study is assess safety, safest dose, and effectiveness of venetoclax in combination with dexamethasone in participants with t(11;14) positive relapsed (comes back) or refractory (did not get better) light chain amyloidosis.
Sponsor: Rajshekhar Chakraborty, MD
Check if you qualify for this light chain amyloidosis clinical trial in New York, NY
If you're searching for light chain amyloidosis treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced light chain amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.